Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from IM Cannabis Corp ( (IMCC) ).
IM Cannabis Corp., a Nasdaq-listed medical cannabis operator in Israel and Germany, is broadening its scope beyond healthcare by targeting technology-driven sectors. The company’s ecosystem spans import and distribution, data-driven patient services, and retail and online channels that provide controlled medical cannabis access in both markets.
The company has signed a non-binding letter of intent to acquire 51% of Polish defense technology firm Blackaxe Technologies, marking a strategic move into cyber drone interception and satellite intelligence. If completed, the deal would shift IMC into defense and homeland security technologies at a time of heightened geopolitical tensions, potentially repositioning its growth profile and exposing investors to fast-growing markets in counter-drone and intelligence solutions.
The most recent analyst rating on (IMCC) stock is a Sell with a $1.00 price target. To see the full list of analyst forecasts on IM Cannabis Corp stock, see the IMCC Stock Forecast page.
Spark’s Take on IMCC Stock
According to Spark, TipRanks’ AI Analyst, IMCC is a Underperform.
The score is driven primarily by weak financial performance—ongoing losses, high leverage relative to equity, and continued cash burn. Technical signals also lean bearish with price below major moving averages and negative MACD, while valuation is difficult to support given a negative P/E and no dividend.
To see Spark’s full report on IMCC stock, click here.
More about IM Cannabis Corp
IM Cannabis Corp. is an international company that operates a medical cannabis platform serving patients in Israel and Germany. Through subsidiaries, it imports and distributes medical cannabis, runs retail pharmacies and online platforms in Israel, and distributes products to German pharmacies via Adjupharm GmbH, while also evaluating expansion into additional technology-driven sectors.
Average Trading Volume: 68,477
Technical Sentiment Signal: Sell
Current Market Cap: $4.15M
Learn more about IMCC stock on TipRanks’ Stock Analysis page.